跳至主要内容
临床试验/EUCTR2019-004975-37-ES
EUCTR2019-004975-37-ES进行中(未招募)1 期

ow INR to Minimize bleeding with mechanical valves Trial - LIMIT

Hamilton Health Sciences through the Population Health Research Institute0 个研究点目标入组 2,660 人开始时间: 2021年6月23日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
2,660

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1) Have had a bileaflet mechanical heart valve implant in the aortic position =3 months ago,
  • 2) Be =18 years of age at the time of enrolment,
  • 3) Provide written informed consent (either from the patient or a substitute decision-maker).
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 1820
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 840

排除标准

  • 1) Have a second implanted mechanical valve (any position),
  • 2) Lower boundary of planned INR range is less than 2.0,
  • 3) Pregnant or expecting to become pregnant during the study follow-up.

研究者

发起方
Hamilton Health Sciences through the Population Health Research Institute

相似试验